PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2141392
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2141392
The Global Egg Protein Hydrolysates Market was valued at USD 242 million in 2025 and is estimated to grow at a CAGR of 6.4% to reach USD 444.9 million by 2035.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $242 Million |
| Forecast Value | $444.9 Million |
| CAGR | 6.4% |
Market volume is projected to increase from 15,800 kilo tons in 2025 to 25,700 kilo tons by 2035. Egg protein hydrolysates are gaining commercial importance as the food and nutrition industries move beyond conventional egg processing toward higher-value functional ingredients. Their market potential depends not only on their protein content but also on the controlled hydrolysis process used to break proteins into shorter peptide chains. This processing approach can improve digestibility, solubility, and functionality for targeted formulations. Growing consumer interest in protein-rich nutrition, functional ingredients, sports nutrition, and specialized dietary products is supporting demand for egg-derived peptide ingredients. Manufacturers are also focusing on processing technologies that can deliver consistent peptide characteristics and application performance. The combination of established egg-processing infrastructure and increasing demand for premium nutritional ingredients is creating opportunities across food, supplement, and clinical nutrition applications. As ingredient developers continue to optimize hydrolysis processes and expand commercial formulations, egg protein hydrolysates are expected to gain broader use through 2035.
Egg white hydrolysates segment held USD 107.7 million in 2025 and is forecast to grow at a CAGR of 6.3% through 2035. Egg white proteins provide a diverse foundation for developing peptide-based ingredients with different functional characteristics. Their nutritional profile and processing versatility continue to support their use in specialized formulations. Research on egg white hydrolysates has highlighted their potential for rapid absorption, which maintains their relevance across sports nutrition and clinical nutrition applications. Continued development of peptide formulations and increasing demand for easily digestible protein ingredients are expected to support segment growth during the forecast period.
Nutraceutical applications segment recorded USD 67.8 million in 2025 and is expected to reach USD 119.8 million by 2035. Egg-derived peptide fractions are incorporated into nutraceutical formulations designed around digestive health, immune support, cardiovascular wellness, antioxidant properties, and anti-inflammatory benefits. Increasing consumer interest in functional nutrition and health-focused ingredients is creating additional opportunities for egg protein hydrolysates within the nutraceutical sector.
North America Egg Protein Hydrolysates Market captured USD 95.6 million in 2025. The United States generated USD 60.9 million in 2025 and benefits from well-established distribution and formulation channels serving sports nutrition, functional beverages, dietary supplements, and clinical nutrition. Integrated egg-processing supply chains also support reliable access to feedstock, while Canada adds regional processing capabilities and contributes to export-focused ingredient trade.
Major companies operating in the global Egg Protein Hydrolysates market include Taiyo Kagaku Co. Ltd., Merck KGaA, Kewpie Corporation, IGRECA, and Rembrandt Foods. Companies in the global Egg Protein Hydrolysates market are strengthening their market foothold through product development, processing technology improvements, capacity expansion, strategic partnerships, and broader distribution networks. Manufacturers are investing in hydrolysis technologies that can improve peptide consistency, solubility, digestibility, and functionality across different formulations. Expanding product portfolios allows companies to address demand from nutraceutical, sports nutrition, clinical nutrition, and functional food applications. Strategic collaborations with food manufacturers, supplement brands, ingredient distributors, and research organizations are helping businesses accelerate formulation development and increase market access. Companies are also optimizing egg-processing and peptide-production operations to improve yields, quality control, and cost efficiency. Geographic expansion is supporting access to new customers and emerging nutrition markets. In addition, businesses are emphasizing technical support, customized ingredient solutions, regulatory compliance, and reliable supply capabilities to build long-term B2B relationships and strengthen their competitive positions.